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Abstract 
Althouh there are normal cognitive changes that take place when a person becomes 
older, aging in humans is generally associated with deterioration of cognitive 
performance and, in particular, of learning and memory. These cognitive deficits can 
cause debilitating consequences due to aging. There are a number of herbal medicines 
which are reported to improve brain function including intelligence. In the present study, 
ameliorating effects of essential oil (EO), extracted from Acori graminei rhizoma 
(AGR), on learning and memory in aged, dysmnesia rats and mice were determined by 
the use of step-down type passive avoidance test or Y type maze trial. Oral 
administration of EO (0.02, 0.04, 0.08 g/kg, in rats given for 30d and in mice for 15d) 
evidently improved the latency and number of errors in aged, dysmnesia rats and mice. 
The cerebral neurotransmitters in aged rats given EO (0.02, 0.04, 0.08 g/kg for 30d) 
were also investigated and, increased levels of norepinephrine (NE), dopamine (DA), 
serotonin (5-HT) and decreased levels of acetylcholine esterase (AChE) activity were 
found. These results suggest that EO improves cognitive function of aged animals and 
may do so by relatively increasing NE, DA, 5-HT levels and by decreasing the activity 
of AChE in the cerebra. 
 
Introduction 
Life expectancy is increasing and there is concern about the incidence of senile 
dementia which results from degeneration of the brain in the absence of cerebrovascular 
disease and, which has very high prevalence in aged people. Its prevalence is estimated 
at 1.53% between 65 and 69 years of age and from the age of 60-80 years relative 
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incidence of senile dementia increases exponentially with age, doubling every five years 
(Preston, 1986; Brayne et al, 1995). However, between the ages of 90 and 94, the 
prevalence is 31.48% of the population (Karen et al, 1995) and these increases as high 
as 44.48% in the age-range 95-99 years (Karen et al, 1995) thus, senile dementia is an 
aged-related disorder. 
There are normal cognitive changes that take place when a person becomes older. 
Aging in humans is associated with deterioration of cognitive performance and, in 
particular, of learning and memory (Erickson et al., 2003) and cognitive deficits are the 
debilitating consequences of aging (Forster et al., 1994). Old, normal aged humans (Uttl 
et al., 1993; Wilkniss et al., 1997; Newman et al., 2000), old monkeys (Lai et al., 1995; 
Rapp et al., 1997), old rats (Barnes, 1979; Markowska et al., 1989; Gallagher et al, 1997) 
and old mice (Bach et al., 1999) all show impairments in learning and memory 
compared with their younger counterparts. For example, Uttl and Graf (1993) studied 
the ability of groups of people from 15 to 74 years of age to navigate through, and 
remember, spatial location information in a museum exhibit. The subjects showed an 
age-related decline in memory for the location of target exhibits, which began to appear 
during the sixth decade. Although changes in memory with age can be variable between 
individuals, and all types of memory are not affected equally, alterations in memory can 
be observed objectively at least by the fifth decade in humans (Albert et al., 1987), and 
many in this age group notice subtle changes in memory. Impairment and decline in 
cognitive function can also be detected in non-demented older people who eventually 
progress to clinically recognisable dementia (Rubin et al., 1998; Albert et al., 2001; 
Chen et al., 2001; Morris et al., 2001; Howieson et al., 2003; Amieva et al., 2005; 
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Tierney et al., 2005).  
For more than a millennium, herbal remedies have been used apparently safely and 
effectively in Asian countries, especially in China, Japan and Korea, as a treatment for 
alleviating various symptoms of cognitive deficits and facilitating learning and memory. 
There are a number of herbal medicines which have been characterized for their effects 
on brain function such as panax ginseng (Jin et al., 1999), Polygala tenuifolia (Chen et 
al., 2004), Ginkgo biloba (Rai et al., 1991; Topic et al., 2002; Olga et al., 2006), Acorus 
gramineus (Bombi et al., 2003; Yoshifumi et al., 2003; Oh MH et al., 2004), and so on.  
Acori graminei rhizoma (AGR) has been used as a treatment for illnesses of the 
brain and for its actions of regaining consciousness, tranquilizing the mind, and 
promoting intelligence, which, in combination with other herbal drugs, is one of the 
most prescribed herbal remedies for treating various kinds of neurological disorders 
such as epilepsy, cerebrovascular diseases, and senile dementia including AD (Liao et 
al., 1998; Hsieh et al., 2000). Anecdotal clinical experiences support the notion that 
AGR is safe and effective in treating and/or alleviating symptoms of these diseases. 
Among 75 of the most famous Chinese complex prescriptions characterized by 
promoting intelligence in past dynasties in China, more than half of these prescriptions 
contain AGR (Liu et al., 2005).  
AGR, the rhizome of Acorus gramineus Schott. (Araceae), contains up to 4.86% of 
essential oil (EO) (Li et al., 2005), which is mainly composed of β-asarone (63.2-81.2%) 
and α-asarone (8.8-13.7%) (Chang et al., 1986). AGR has been shown to affect the 
central dopaminergic and GABA systems (Liao et al., 1998), and its major component 
asarone, has a neuroprotective effect against excitotoxic neural death (Cho et al., 2000, 
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2002). Hsieh et al. (2000) reported cognitive enhancing effects of AGR on 
scopolamine-induced amnesia in rats. In addition, AGR has protective effects against 
ischemia-induced neuronal loss and learning and memory damage in rats (Bombi et al., 
2003). As far as we are aware, no reports have been issued on the facilitating effects of 
EO from AGR on learning and memory in aged animals until the present time. 
In the current experiments, we investigated the effects of EO from AGR on 
cognitive functions of young, aged animals and chemical-induced dysmnesia subjects. 
Learning and memory parameters in these subjects were evaluated using step-down type 
passive avoidance task and Y type maze trial. Previous studies have shown that aged 
animals and chemical-induced dysmnesia subjects perform poorly compared with young 
in the animal models used (Luo et al., 2003; Adriana et al., 2004). Step-down trial can 
examine ability of passive avoidance response, while ability of spatial memory in 
animals can also be determined by the use of Y-maze task. Although some investigators 
have argued against the usefulness of passive avoidance testing to evaluate learning and 
memory in animals (LeDoux, 1993), it is generally accepted as an indicator of 
long-term memory. In addition, this study also examined the effects of EO on levels of 
monoaminergic neurotransmitters (NE, DA and 5-HT), together with AChE activity in 
cerebra of aged rats, all of which are known to be important to mediation of learning 
and memory processes. 
 
Materials and Methods  
Preparation of EO from AGR 
AGR was purchased from Chengdu Tong-ren-tang Pharmaceutical Group, and 
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identified as the rhizoma of Acorus tatarinowii Schott. by Professor D-G Wan, a 
pharmacognosist, from The Pharmacy Faculty of Chengdu University of Traditional 
Chinese Medicine (Chengdu, China). The EO was extracted by the use of 
hydrodistillation. The dried rhizomes were broken into small segments, 10kg of which 
were immersed in 50L distilled water, and boiled in a distillation apparatus for 10h. The 
yield of EO was 3.04% (v/w) and it was stored at +4°C until utilized.   
GC–MS analysis 
GC–MS was performed with an Agilent 6890 gas chromatography instrument coupled 
to an Agilent 5973 mass spectrometer and an Agilent ChemStation software (Agilent 
Technologies, Palo Alto, CA, USA). Compounds were separated on a 30m×0.32mm i.d. 
capillary column coated with 0.25 μm film 5% phenyl methyl siloxane. The column 
temperature program began at 60ºC and was held for 1 min, then increased at a rate of  
3ºC min−1 to 220 ºC and held for 5 min. Split injection (2μl) was conducted with a split 
ratio of 1:30 and helium was used as carrier gas at a flow rate of 1.3 ml min−1.  The 
spectrometers were operated in electron-impact (EI) mode and the ionization energy 
was 70 eV. The inlet, ionization source temperatures were 250ºC and 280ºC, 
respectively. The GC-MS analysis showed that the main components of EO were 
β-asaricin and α-asaricin, having a relative content 63.37% and 4.12% (w/w), 
respectively.  
Administration of EO from AGR 
EO was dissolved in 3% tween-80 and distilled water prior to administration. Three 
groups of animals (n=10) were orally administered 0.02, 0.04, 0.08g/kg.d-1of EO by 
intubation respectively, mice were administered for 15 days whilst the rats were 
 7 
administered for 30 days. Two more groups of animals (normal and control groups) 
were orally administered vehicle (3% tween-80), and they were run concurrently with 
EO-treated groups. EO and vehicle were given in a volume of 10 ml/kg body weight 
irrespective of dose.  
Animals and grouping 
Animals, obtained from Experimental Animal Center of Chengdu University of 
Traditional Chinese Medicine (Chengdu, China), were housed in a regulated 
environment (20±1ºC), with a 12-h light and 12-h dark cycle (08:00-20:00, light)and 
were grouped as follows: Young  and aged male Kunming mice, (30 days of age, 
18-22g; 12-13 months of age, 40-50g, respectively), Grade II, Certificate No 2000-7. 
Young and aged male Sprague–Dawley rats, (90 days of age, 180-220g; 24-25 months 
of age, 550-650g, respectively), Grade II, Certificate No 2000-8. Food and water were 
given ad libitum, except for the duration of the experimental session. On the day of the 
experiment, animals were brought to the experimental room and allowed to habituate to 
the environmental conditions for a period of approximately 60 min before the beginning 
of the experiment. All animal treatments were strictly in accordance with international 
ethical guidelines and National Institutes of Health Guide concerning the Care and Use 
of Laboratory Animals and the experiments were carried out under the approval of the 
Committee of Experimental Animal Administration of the University.  
In the experiment on the effects of EO on learning performances in aged mice, forty 
aged mice were divided into four groups (n=10) ad libitum, namely, three EO-treated 
groups (0.02, 0.04, 0.08g/kg.d-1) and one control group. Another ten young mice served 
as normal group. In the experiment on the effects of EO on learning performances in 
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aged rats, forty aged rats were divided into four groups (n=10) ad libitum, viz. three 
EO-treated groups (0.02, 0.04, 0.08g/kg.d-1) and one control group and another ten 
young rats served as the normal group. In the experiments on the effects of EO on 
dysmnesia, animals were induced by scopolamine (mice), sodium nitrite (rats) or 
ethanol (mice), 40 young subjects were divided into four groups (n=10) ad libitum, viz. 
three EO-treated groups (0.02, 0.04, 0.08g/kg.d-1) and one control group. Another ten 
young subjects served as normal group. In the experiment on  the effects of EO on 
cerebral 5-HT, NE, and DA levels in aged rats, forty aged rats were divided into four 
groups (n=10) ad libitum, viz. three EO-treated groups (0.02, 0.04, 0.08g/kg.d-1) and 
one control group. Another ten young rats served as normal group. In the experiment on 
the effects of EO on cerebral AChE activity in aged rats, grouping was the same as 
outlined above. 
Chemicals and modeling  
Scopolamine (Mingxing pharmaceutical factory, Guangzhou, China) and sodium nitrite 
(Chengdu chemical reagent factory, China) were dissolved in sterile 0.9% saline, 
respectively. Ethanol was diluted to a concentration of 30% (v/v) with distilled water. 
All chemicals were administered intraperitoneally in a volume of 5 ml/kg body weight 
irrespective of dose. Control and normal animals received respective solvent injections, 
and they were run concurrently with drug-treated groups.  
In experiments on the effects of EO on dysmnesia animal models, Scopolamine (1 
mg/kg, i.p.) was administered 30 min before the training trial and induced memory 
acquisition impairment of mouse; sodium nitrite (120mg/kg, i.p.) was injected 
immediately after the training trial and induced memory consolidation impairment of rat; 
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and finally 30% of alcohol (1.5g/kg, i.p.) was injected thirty minutes before testing trial 
and induced memory retrieval impairment of mice.  
Behavioral testing 
Step-down test  
The method described by Xu et al. (2002) served as the reference. The apparatus 
consisted of acrylic box (20×20×20cm high) with a stainless-steel grid floor and a 
wooden platform (4×4×4cm) was fixed at the center of the box. Electric shocks (36V) 
were delivered to the grid floor for 6s with an isolated pulse stimulator. At the beginning 
of training trial, mice were placed in the box to adapt for 3min. After 3 min, electric 
shocks were delivered and, mice jumped on the platform to avoid noxious stimulation 
and the shocks maintained for 5min. After a 24h interval, mice were again placed on the 
platform, and their latency to step down on the grid with all four paws for the first time 
and number of errors subjected to shocks within 5min were measured as learning 
performances.  
Y-maze test 
The Y-maze was used for behavioral testing of spatial recognition memory and the 
method described by Xu et al. (2002) served as the reference. The apparatus with a 
conductive grid floor consisted of three identical arms (60l×16w×32h cm) made of dark 
opaque Plexiglas and these three arms were symmetrically disposed at 120° to each 
other. Arms Ⅰand Ⅲ were non-safety zone (shocks were administered via these) and 
arm Ⅱ was a safety zone (on the top of which there was an insulated grid floor of 
16×25cm). Rats were placed on the top of armⅠand a fixed resistance shock source 
was connected to an automatically operated switch and electric shocks (50V) were 
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applied. After shocking, rats escaped from foot shocks by accidentally entering the top 
of arm Ⅱ and this was counted as one practice and the rats were repeatedly trained for 
this procedure a further 10 times. After a 24h interval the rats were successively tested 
for 10 times and their latency to enter safety zone (i.e. insulated grid floor) from 
non-safety zone for the first time and number of errors displayed by entering the 
non-safety zone within 10 times were recorded as learning performances. 
Assays of NE, DA, 5-HT levels  
For determination of cerebral levels of 5-HT, NE, and DA, three groups of aged rats 
(n=10) received 0.02, 0.04 or 0.08 g/kg.d-1 po of EO for 30d before decapitation. Two 
more groups of animals (n=10), serving as normal group (young rats) and control group 
(aged rats), were given orally vehicle by intubation respectively, and run concurrently 
with EO-treated groups. Animals were decapitated and skulls were split on ice and salt 
mixture and the cerebra were isolated, weighed, and homogenized in ice-cold n-butanol 
solution (5 ml/g tissue) according to Miller et al. (1970) and Biochemistry group of 
acupuncture and Meridian Research Institute of TCM academy (1975). Homogenization 
was performed using ice-cold homogenizer for 1 min and a 20% homogenate was made 
which was then centrifuged at 3000 rpm for 5 min. Supernatant (2.5ml) was then 
transferred to a tube containing 1.6 ml of 0.2 N acetic acid and 5 ml n-heptane. After 
mixing on a vortex mixer for 30 s, the tubes were centrifuged at 3000 rpm for 5 min. 
The aqueous phases were used for the estimation of 5-HT, NE, and DA levels 
employing the fluorospectrophotometry (850 type, HIITACHI Corp. Japan) reported by 
Ciarlone (1978).  
Assay of AChE activity  
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For the determination of cerebral AChE activity, three groups of aged rats (n=10) 
received 0.02, 0.04 or 0.08 g/kg.d-1 po of EO for 30d before decapitation. Two more 
groups of animals (n=10), serving as normal group (young rats) and control group (aged 
rats), were given orally vehicle by intubation respectively, and run concurrently with 
EO-treated groups. Animals were decapitated and skulls were split on ice and salt 
mixture and the cerebra were isolated, weighed, and homogenized in phosphate buffer, 
pH 8.0 (1 ml/40 mg tissue), for 1 min and a 4% homogenate was made. Estimation of 
the cerebral AChE activity was performed with some modifications to the assay 
described by Ellman et al. (1961) and Zhengxin Ni (1990). 
Statistical Analysis 
The data were analyzed using a statistical package (SPSS10.0). The data for multiple 
comparisons were performed by one-way ANOVA followed by Dunnett's t-test. P<0.05 
was considered statistically significant and all results are presented as the mean±SD. 
 
Results 
Effects of EO on learning performances in aged mice（Table 1） 
In the control group containing aged mice, the latencies significantly shortened and the 
number of errors markedly increased compared to the normal group by the step-down 
test. In contrast, in aged mice treated by EO (0.04, 0.08g/kg.d-1) for 15 days, learning 
performances were manifestly improved, except at the lower dose group of EO 
(0.02g/kg.d-1), which was similar to that observed in the control group. 
Effects of EO on learning performances in aged rats（Table 2） 
In aged rats of control group, the latencies were significantly prolonged and the number 
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of errors markedly increased in contrast to young rats by the Y-maze test. However, in 
EO-treated groups (0.04, 0.08g/kg.d-1 still for 30 days), learning performances were 
manifestly improved, except for the number of errors at the lower dose group of EO 
(0.02g/kg.d-1), which had no statistical significance compared with control group.  
Effects of EO on dysmnesia mice induced by scopolamine（Table 3） 
A 1mg/kg dose of scopolamine was injected ip 30min before the training trial in the 
induced memory acquisition impairment model, and this impaired the step-down type 
passive avoidance test performance of mice. Mice of control group, displayed poor 
performances, whose latencies shortened and the number of errors increased as 
determined by the step-down test. In contrast, EO (0.02, 0.04, and 0.08g/kg), given for 
15d, significantly improved the performances of dysmnesia mice. 
Effects of EO on dysmnesia rats induced by sodium nitrite（Table 4） 
The results presented in Table 4 indicate that sodium nitrite impaired the Y-maze type 
test performances of rats. EO produced an overall statistically significant and 
dose-dependent improvement in performances of rats at doses of 0.02, 0.04, 0.08g/kg, 
that is to say, the latencies evidently shortened and the number of errors markedly 
decreased compared to the control group.  
Effects of EO on dysmnesia mice induced by ethanol (Table 5) 
Thirty minutes before testing trial, mice were intraperitoneally injected with 30% 
alcohol, which evidently impaired the step-down type passive avoidance test 
performances as indicated in Table 5. EO (0.02, 0.04, 0.08g/kg) increased step-down 
latencies and decreased the number of errors in dose-dependent manner, the EO-treated 
groups differed significantly from the control group. 
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Effects of EO on cerebral 5-HT, NE, and DA levels in aged rats（Table 6） 
As can be seen in Table 6 in the control group consisting of aged rats the levels of 
cerebral NE, DA, and 5-HT were significantly decreased compared to those observed in 
the rats in the normal group. When the aged rats were given EO at a dosage of 0.08 g/kg 
the levels of NE, DA and 5HT were similar to those observed in the normal group, this 
difference being statistically significant. At an EO dosage of 0.04g/kg only NE and DA 
levels were significantly increased when compared to the values observed in the control 
group. However, at an EO dosage of 0.02g/kg only NE levels were statistically 
significant when compared to the values observed in the control group. At this dosage 
although there was some improvement in the levels of DA and 5HT, this change was 
not statistically significant.  
Effects of EO on AChE activity in cerebra of aged rats（Figure 1） 
As can be seen in Fig.1, in the control group consisting of aged rats there was a 
significant increase in the activity of cerebral AChE when compared to the values 
observed in the cerebra of the rats in the normal group. This increase in the activity of 
AChE was significantly reversed when the rats were given EO at dosages of 0.02, 0.04, 
0.08 g/kg 30 days when compared to the control group.  
 
Discussion  
Ethologic investigation of learning and memory is at present one of the most reliable 
targets reflecting levels of animal intelligence. Many nootropic studies investigate 
animal’s behavior changes using step-down, step-through, maze test, etc., which are 
often applied for the determination of capabilities of passive avoidance and spatial 
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memory in animals (Jair et al., 2005; Farr et al., 2006; Türkmen et al., 2006; Um et al., 
2006). Cognitive deficits are often observed in aged humans, as well as in various 
neurological conditions. The present study assessed the effects of EO from AGR on 
learning and memory in aged mice and rats using step-down and Y-maze test. The 
results demonstrated improvements in learning performances in aged mice receiving EO 
by an increased latency and a decreased number of errors in the step-down test, and in 
aged rats receiving EO by a decreased latency and a decreased number of errors in the 
Y-maze test.  
Generally, memory as measured by changes in an animal’s behavior some time after 
learning, is considered to be a process that has several stages, including acquisition, 
consolidation and retrieval (Abel and Lattal, 2001). The use of pharmacological, genetic 
and lesion approaches has helped to define the brain systems and molecular processes 
important for these different stages of memory. For example, in the experiment 
containing contextual fear conditioning, memory acquisition occurs as the animal learns 
an association between a context and a shock. During consolidation, which can last 
from minutes to days, this memory is moved from a labile to a more fixed state and 
during retrieval, the animal is returned to the conditioning context, where memory for 
the context-shock association is assessed (Abel and Lattal, 2001).  
Some chemical agents, such as scopolamine, sodium nitrite and ethanol, impair 
memory in animals trained on a step-down type passive avoidance and a radial maze 
type task (Lu, 2001; Jill et al., 2003; Reinaldo et al., 2005), which are used to measure 
the three stages of memory process depending on drug-treated period. As revealed by 
many studies on cognitive function, a single intraperitoneal injection of scopolamine 
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hydrobromide (0.5-1mg/kg) 10-30 min prior to training significantly impairs the ability 
for animal’s memory acquisition (Anagnostaras et al., 1995; Gibbs et al., 1998; Jill et al., 
2003). Sodium nitrite when injected immediately after training trial demolishes memory 
consolidation, and 10-30% ethanol injected 30 min before testing trial disturbs memory 
retrieval (Vikas et al., 2000; Luo et al., 2003; Kim et al., 2005). In the present study, 
mice given scopolamine or 30% ethanol, displayed poor performances, whose latency 
shortened and the number of errors were increased as determined by the step-down test; 
administration of sodium nitrite in rats evidently increased the latency and the number 
of errors. The administration of EO from AGR improved cognitive behavior in 
dysmnesia animals to a great degree. EO (0.02, 0.04, and 0.08 g/kg) showed a 
dose-dependent effect on acquired learning of mice with scopolamine-induced 
dysmnesia. The observed results of EO at the same doses on other memory stages also 
revealed a dose-dependent effect, such as consolidation and retrieval. Taking all these 
observations into account including latency and error numbers, we proposed that EO at 
the dose of 0.02 g/kg can overcome amnesia at the three stages of the memory process.  
Learning and memory is one of the most important functions of the brain, which is 
associated with complex neurophysiologic and neurochemical changes. Many 
neurotransmitters, including acetylcholine (ACh), dopamine (DA), norepinephrine (NE), 
and, serotonin (5-HT) play an important role in the learning and memory processes 
(Arjan, 1996; Trond, 2003). ACh has been related to attentional processes 
(Himmelheber et al., 2000) and plays an important role in cognitive processing. It has 
been reported that administration of scopolamine or atropine induces memory 
dysfunction in rats, primates, and humans (Blozovski et al., 1977; Drachman, 1977; 
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Aigner and Mishkin, 1986). This drug-induced impairment is subsequently reversed 
after displacement of the blocking agent (Dawson et al 1992), and by the use of AchE 
inhibitors. These drugs act by preventing the breakdown of Ach in the synaptic cleft. 
The administration of physostigmine to both young and aged monkeys produces an 
overall improvement of mnemonic processes in both groups (Bartus and Uehara, 1979). 
DA has been associated with motivational processes (Wilson et al., 1995) and has a 
special role in appetitively motivated tasks. The use of dopaminergic antagonists, 
especially those more selective for the D1 receptor such as SCH2330, worsens 
performance in the delayed response paradigm (Didriksen, 1995). This is consistent 
with anatomical data indicating that the D1 receptor is the most abundant dopaminergic 
receptor in the mammalian brain (Cortes et al., 1989； Goldman-Rakic et al., 1990), and 
therefore is the most likely to be involved in the cognitive processes mediated by 
dopamine in the brain. Central serotonin (5-HT) has been linked to emotional processes 
(Hashimoto et al., 1999) and plays a particular role in emotionally related tasks and 
despite the lack of functional specialisation, the serotonergic system plays a significant 
role in learning and memory (Buhot et al., 2000). Administration of 5-HT2A/2C or 5-HT4 
receptor agonists or 5-HT1A or 5-HT3 and 5-HT1B receptor antagonists prevents memory 
impairment (Buhot et al., 2000) and has utility in treatment of Alzheimer’s disease and 
amnesia (Menses, 1998). L-tryptophan, the precursor of serotonin, is reported to 
enhance memory functions in schizophrenic and depressed patients (Riedel et al., 1999; 
Levkovitz et al., 2003) whilst NE has been relevant to learning and memory 
consolidation, possibly by acting as a regulation of signal (Crow, 1968; Kety, 1970). 
Cognitive deficits induced by various lesions to the locus ceruleus are reversible by the 
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administration of drugs that enhance noradrenergic neurotransmitter. The administration 
of diethyldithiocarbamate, an inhibitor of the enzyme dopamine-beta-hydroxylase, to 
rats, depletes norepinephrine stores in the brain, and produces complete retention failure 
of passive avoidance learning (Stein et al., 1971; Hamburg et al., 1973). Subsequently, 
normal learning of the passive avoidance task is restored in 
diethyldithiocarbamate-treated rats with a single intraventricular dose of NE (Stein et al., 
1975).  
Aging is often accompanied by some alterations in the neurotransmitter systems of 
humans and other mammals (Arranz et al., 1996; Magnone et al., 2000; Monica et al., 
2003). Most of the studies on brain physiology in aging have been performed in rodents 
and the results do not always show consistent changes in the neurochemical parameters. 
Some of the discrepancies observed may be due to species or strain differences. 
Nevertheless, the published work appears to agree with respect to several aspects such 
as the reductions of the levels of neurotransmitters, including ACh, DA, NE, 5-HT 
which have been demonstrated in the aging brain (Habib et al., 2001; Monica et al., 
2003). Our findings demonstrate that reductions in the levels of DA, NE, 5-HT 
significantly decreased and AchE activity markedly increased in aging brain which is 
consisted with earlier reports (Habib et al., 2001; Monica et al., 2003). However, the 
most significant result of our study is that the administration of EO caused significant 
increases in the levels of DA, NE, 5-HT whilst significantly decreasing the activity of 
AChE in the cerebra of aged rats.  
Conclusion 
In summary, the administration of EO significantly enhances learning performances in 
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aged rats and mice. It also ameliorates memory deficits in amnesic rats and mice 
induced by chemical agents, which are associated with increases of NE, DA, 5-HT 
levels, and a decrease in the activity of AChE in the cerebra. Since a desirable cognitive 
effect has been reported for glutamate (Ohno and Watanabe, 1996; Trond, 2003), 
further studies should be directed towards investigating the effect of EO on 
glutamatergic neurotransmitter in brain areas implicated in the control of learning and 
memory processes. In addition, Beta-asarone and alpha-asarone are two major 
components of EO extracted from Acori graminei rhizome, which are able to ameliorate 
learning and memory, however, their facilitating effects on cognitive function are 
inferior to EO (Hu et al., 1999; Wu et al., 2004). Since EO is an effective part of Acori 
graminei rhizoma and contains a mixture of active components, it may be exerting its 
effects through multiple components. Although this is an animal based study it is 
proposed that EO may be effective in the improvement of brain function in elderly 
humans.  
Acknowledgements 
The authors are grateful to Drs. Baokang Huang, Qiaoyang Zhang and Professor 
Hanchen Zheng (Department of Pharmacognosy, School of Pharmacy, Second Military 
Medical University, Shanghai 200433 P. R. China) for technical assistance. 
 
References 
Abel, T., Lattal, K. M. (2001) Molecular mechanisms of memory acquisition, consolidation and 
retrieval. Curr. Opin. Neurobiol. 11:180-187  
Adriana, L. S., Angelo, L. P., Simone, B., Carlos, A. N., Domingos, S. N., Elaine, E. (2004) 
 19 
Memory retrieval improvement by Ptychopetalum olacoides in young and aging mice. J. 
Ethnopharmacol. 95:199-203 
Aigner, T., Mishkin, M. (1986) The effects of physostigmine and scopolamine on recognition 
memory in monkeys. Behav. Neural. Biol. 45:81-87 
Albert, M. S., Duffy, F., Naeser M. (1987) Non-linear changes in cognition with age and 
neurophysiological correlates. Can. J. Psychol. 41:141-157 
Albert, M. S., Moss, M., Tanzi, R., Jones, K. (2001) Preclinical prediction of AD using 
neuropsychological tests. J. Int. Neuropsych. Soc. 7: 631-639 
Amieva, H., Jacqmin-Gadda H, Orgogozo, J. M., Le, Carret, N., Helmer, C., Letenneur, L., et al. 
(2005) The 9 year cognitive decline before dementia of the Alzheimer type: A prospective 
population-based study. Brain 128:1093-1101 
Anagnostaras, S. G., Maren, S., Fanselow, M. S. (1995) Scopolamine Selectively Disrupts the 
Acquisition of Contextual Fear Conditioning in Rats. Neurobiol. Learn Mem. 64: 191-194  
Arjan, Blokland. (1996) Acetylcholine: a neurotransmitter for learning and memory? Brain, Res. 
Rev. 21:285-300 
Arranz, B., Blennow, K., Ekman, R., Eriksson, A., Mansson, J. E., Marcusson, J. (1996) Brain 
monoaminergic and neuropeptidergic variations in human aging. J. Neural. Transm. 103:101-115 
Bach, M. E., Barad, M., Son, H., Zhuo, M., Lu, Y. F., Shih, R., Mansuv, I., Hawkins, R. D., Kandel, 
E. R. (1999) Age-related defects in spatial memory are correlated with defects in the late phase 
of hippocampal long-term potentiation in vitro and are attenuated by drugs that enhance the 
cAMP signaling pathway. Proc. Nat.l Acad. Sci. USA 96:5280-5285 
Barnes, C.A. (1979) Memory deficits associated with senescence: a neurophysiological and 
behavioral study in the rat. J. Comp. Physiol. Psychol. 93:74–104  
 20 
Bartus, R., Uehara, Y. (1979) Physostigmine and recent memory: Effects in young and aged 
nonhuman primates. Science 206:1085-1087 
Biochemistry group of acupuncture and meridian research institute of TCM academy. (1975) 
Simultaneously extraction and fluorospectrophotometry determination of 5-HT, 5-HIAA, NE, 
DA in brain. TCM Research References (7):38 
Blozovski, D., Cudennec, A., Garrigou, D. (1977) Deficits in passive avoidance learning following 
atropine in the developing rat. Psychopharmacology 54:139-144 
Bombi, Lee., Young, K. C., Hocheol, K., Sun, Y. K., Hahm, D. H., Lee, H. J., Insop, S. (2003) 
Protective effects of methanol extract of Acori graminei rhizome and Uncariae Ramulus et 
Uncus on ischemia-induced neuronal death and cognitive impairments in the rat. Life, Sci. 
74:435-450 
Brayne, C., Gill, C., Hupert, F. A., et al. (1995) Incidence of clinically diagnosed subtypes of 
dementia in an elderly population. Brit. J. Psychiat. 167:255-262 
Buhot, M. C., Martin, Segu, L. (2000) Role of serotonin in memory impairment. Ann. Med. 32: 
210-221 
Chang, H. H., But, PPH. (1986) Pharmacology and Applications of Chinese Materia Medica. 
1:334-337 
Chen, P., RatcliV, G., Belle, S. H., Cauley, J., DeKosky, S. T., Ganguli, M. (2001) Patterns of 
cognitive decline in presymptomatic Alzheimer’s disease: A prospective community study. Arch. 
Gen. Psychiat. 58:853-858  
Chen, Y. L., Hsieh, C. L., Wu, P-H. B., Lin, J. G.. (2004) Effect of Polygala tenuifolia root on 
behavioral disorders by lesioning nucleus basalis magnocellularis in rat. J. Ethnopharmacol. 
95:47-55 
 21 
Cho, J., Joo, N. E., Kong, J.Y., Jeong, D. Y., Lee, K. D., Kang, B. S. (2000) Inhibition of excitotoxic 
neuronal death by methanol extract of Acori graminei rhizoma in cultured rat cortical neurons. J. 
Ethnopharmacol. 73:31-37 
Cho, J., Kim, Y. H., Kang, J. Y., Yang, C. H., Park, C. G. (2002) Protection of cultured rat cortical 
neurons from excitotoxicity by asarone, a major essential oil component in the rhizomes of 
Acorus gramineus. Life. Sci. 71:591-599 
Ciarlone, A. E. (1978) Further modification of a fluorometric method for analyzing brain amines. 
Microchem. J. 23: 9-12 
Cortes, R., Gueye, B., Pazos, A., Probs, A., Palacios, J. M. (1989) Dopamine receptors in the human 
brain: Autoradiographic distribution of D1 sites. Neuroscience 28:263-723. 
Crow, T. J. (1968) Cortical synapses and reinforcement: a hypothesis. Nature 219:736-737 
Dawson, G., Heyes, C., Iversen, S. (1992) Pharmacological mechanisms and animal models of 
cognition. Behav. Pharmacol. 3:285-297 
Didriksen, M. (1995) Effects of antipsychotics on cognitive behavior in rats using the delayed 
non-match to position paradigm. Eur. J. Pharmacol. 281:241-250 
Drachman, D. (1977) Memory and cognitive function in man. Does the cholinergic system have a 
specific role? Neurology 27:783-90. 
Ellman, G. L., Lourtney, D. K., Andres, V., Gmelin, G. (1961) A new and rapid colorimetric 
determination of acetylcholinesterase activity. Biochem. Pharmacol. 7: 88–95 
Erickson, C. A., Barnes, C. A. (2003) The neurobiology of memory changes in normal aging. Exp. 
Gerontol. 38:61-69 
Farr, S. A., Banks, W. A., Morley, J. E. (2006) Effects of leptin on memory processing. Peptides 
27:1420-1425 
 22 
Forster, M. J., Dubey, A., Dawson, K. M., Stutts, W. A., Lal, H., Sohal, R. S. (1994) Age-related 
losses of cognitive function and motor skills in mice are associated with oxidative protein 
damage in the brain. P. Natl. Acad. Sci. USA 93:4765-4769 
Gallagher, M., Rapp, P. R. (1997) The use of animal models to study the effects of aging on 
cognition. Ann. Rev. Psychol.48:339-370  
Gibbs, R. B., Burke, A. M., Johnson, D. A. (1998) Estrogen Replacement Attenuates Effects of 
Scopolamine and Lorazepam on Memory Acquisition and Retention. Horm. Behav. 34: 112-125 
Goldman-Rakic, P. S., Lidow, M. S., Gallager, D. W. (1990) Overlap of dopaminergic, adrenergic 
and serotoninergic receptors and complementarity of their subtypes in primate prefrontal cortex. 
J. Neurosci. 10:2125-2138 
Habib, U. Rehman, Ewan, A. Masson. (2001) Neuroendocrinology of ageing. Age Ageing 
30:279-287 
Hamburg, M. D., Cohen, R. P. (1973) Memory access pathway: Role of adrenergic versus 
cholinergic neurons. Pharmacol. Biochem. Behav. 1:295-300 
Hashimoto, S., Inoue, T., Koyama, T. (1999) Effects of conditioned fear stress on serotonin 
neurotransmission and freezing behavior in rats, Eur. J. Pharmacol. 378:23-30 
Himmelheber, A. M., Sarter, M., Bruno, J. P. (2000) Increases in cortical acetylcholine release 
during sustained attention performance in rats, Cogn. Brain, Res. 9:313-325 
Howieson, D., Camicioli, R., Quinn, J., Silbert, L. C., Care, B., Moore, M. M., et al. (2003) Natural 
history of cognitive decline in the old. Neurology 60:1489-1494 
Hsieh, M. T., Peng, W. H., Wu, C. R., Wang, W. H. (2000) The ameliorating effects of the 
cognitive-enhancing Chinese herbs on scopolamine-induced amnesia in rats. Phytother. Res. 
14 :375-377 
 23 
Hu, J. G., Gu, J., Wang, Z. W. (1999) Effects of active principles extracted from Acori graminei 
rhizoma on learning and memory. Journal of Chinese Medicinal Materials 22:584-585  
Jair Guilherme dos Santos Juniora, Fabrı´cio Hoffmann Martins do Monteb, Miriam Marcela Blanco, 
Vanusa Maria do Nascimento Bispo Lanziotti, Fla´vio Damasseno Maiac, Luzia Kalyne de 
Almeida Leal. (2005) Cognitive enhancement in aged rats after chronic administration of 
Equisetum arvense L. with demonstrated antioxidant properties in vitro. Pharmacol. Biochem. 
Be. 81: 593-600 
Jill, M. D., Peter, J. W., Joseph, M. M. (2003) Castration in rats impairs performance during 
acquisition of a working memory task and exacerbates deficits in working memory produced by 
scopolamine and mecamylamine. Psychopharmacology 170:294-300 
Jin, S. H., Park, J. K., Nam, K. Y., Park, S. N., Jung, N. P. (1999) Korean red ginseng saponins with 
low ratios of protopanaxadiol and protopanaxatriol saponin improve scopolamine-induced 
learning disability and spatial working memory in mice. J. Ethnopharmacol. 66:123-129 
Karen, R., Daniel, K. (1995) Is senile dementia "age-related" or "ageing-related"?-evidence from 
meta-analysis of dementia prevalence in the oldest old. Lancet 346:931-934 
Kety, S. S. The biogenic amines in the central nervous system: their possible roles in arousal, 
emotion, and learning. In F.O. Schmitt (Ed.), The Neurosciences, Second Study Program, 
Rockefeller University Press, New York, 1970, pp. 324-336 
Kim, G. C., Hellemans, José N Nobrega, Mary C Olmstead. (2005) Early environmental experience 
alters baseline and ethanol-induced cognitive impulsivity: relationship to forebrain 5-HT1A 
receptor binding. Behav. Brain Res. 159:207-220  
Kumar, V., Singh, P. N., Muruganandam, A. V., Bhattacharya, S. K. (2000) Effect of Indian 
Hypericum perforatum Linn on animal models of cognitive dysfunction. J. Ethnopharmacol. 
 24 
72:119-128 
Lai, Z. C., Moss, M. B., Killiany, R. J., Rosene, D. L., Herndon, J. G. (1995) Executive system 
dysfunction in the aged monkey: spatial and object reversal learning. Neurobiol. Aging 
16:947-954 
Levkovitz, Y., Ophir-Shaham, O., Block, Y., Treves, I., Fenning, S., Grauer, E. (2003) Effects of 
l-tryptophan on memory in patients with schizophrenia. J. Nerv. Ment. Dis. 191:568-573 
LeDoux, J.E. (1993) Emotional memory systems in the brain. Behav. Brain Res. 58:69–79. 
 Li, B., Han, L., Peng, H. S., Tang, Y. L. (2005) Super critical carbon dioxide extraction of Rhizoma 
Acori Tatarinowii oil. Chemistry World (4): 213-215 
Liao, J. F., Huang, S. Y., Jan, Y. M., Yu, L. L., Chen, C. F. (1998) Central inhibitory effects of water 
extract of Acori graminei rhizoma in mice. J. Ethnopharmacol. 61:185-193 
Liu, W. B., Liu, W. Z. (2005) Disciplinarian investigation of Chinese complex prescription with 
promoting intelligence in past dynasties. jiangxi journal of traditional Chinese medicine. 
36:62-63 
Lu, M. C. (2001) Danggui Shaoyao San improve colchicine-induced learning acquisition impairment 
in rats. Acta Pharmacol. Sin. 22: 1149-1153 
Luo, J., Yin, J. H., Wu, H. Z., Wei, Q. (2003) Extract from Fructus cannabis activating calcineurin 
improved learning and memory in mice with chemical drug-induced dysmnesia. Acta Pharmacol. 
Sin. 24: 1137-1142 
Magnone, M. C., Rossolini, G., Piantanelli, L., Migani, P. (2000) Neurochemical parameters of the 
main neurotransmission systems in aging mice. Arch. Gerontol. Geriatr. 30:269-279 
Markowska, A. L., Stone, W. S., Ingram, D. K., Reynolds, J., Gold, P. E., Conti, L. H., Pontecorvo, 
M. J., Wenk, G. L., Olton, D. S. (1989) Individual differences in aging: behavioral and 
 25 
neurobiological correlates. Neurobiol. Aging 10: 31-43  
Menses, A. (1998) Physiological, pathophysiological and therapeutic roles of 5-HT systems in 
learning and memory. Rev. Neurosci. 9:275-289 
Miller, F. P., Cox, J. RH., Snodgrass, W. R., Maickel, R. P. (1970) Comparative effects of 
p-chlorophenylalanine, p-chloroamphetamine and p-chloro-N-methylamphetamine on rat brain 
norepinephrine, serotonin and 5-hydroxyindole-3-acetic acid. Biochem. Pharmacol. 19:435-442 
Monica De la Fuente, Angel Hernanz, Sonia Medina, Noelia Guayerbas, Beatriz Fernández, Maria 
Paz Viveros. (2003) Characterization of monoaminergic systems in brain regions of prematurely 
ageing mice. Neurochem. Intl. 43:165-172 
Morris, J. C., Storandt, M., Miller, J. P., McKeel, D. W., Price, J. L., Rubin, E. H., et al. (2001) Mild 
cognitive impairment represents early-stage Alzheimer’s disease. Arch. Neurol-Chicago 
58:397-405  
Newman, M. C., Kaszniak, A. W. (2000) Spatial memory and aging: performance on a human 
analog of the Morris water maze. Aging Neuropsychol. Cogn. 7;86-93 
Ni, Z. X. (1990) Improvement of Ellman assay of AchE in brain. Journal of NanTong Medical 
College 10: 239 
Oh, M. H., Houghton, P. J., Whang, W. K., Cho, J. H. (2004) Screening of Korean herbal medicines 
used to improve cognitive function for anti-cholinesterase activity. Phytomdicine 11:544-548 
Ohno, M., Watanabe, S. (1996) Interactive processing between glutamatergic and cholinergic 
systems involved in inhibitory avoidance learning of rats. Eur. J. Pharmacol. 312:145–147 
Olga, S., Katie, G., Christa, M. D., Courtney, C., Robbins, S. J., Hoffman, J. R. (2006) Effects of 
Ginkgo biloba administered after spatial learning on water maze and radial arm maze 
performance in young adult rats. Pharmacol. Biochem. Be. 84:17-25 
 26 
Preston, G. A. (1986) Dementia in elderly adults: Prevalence and institutionalization. J. Gerontol. 
41:261-267 
Rai, G. S., Sholvin, C., Wesener, K. A. (1991) A double-blind, placebo-controlled study of Ginkgo 
biloba extract in elderly outpatients with mild to moderate memory impairment. Curr. Med. Res. 
Opin. 12:350-355 
Rapp, P. R., Kansky, M. T., Roberts, J. A. (1997) Impaired spatial information processing in aged 
monkeys with preserved recognition memory. Neuroreport 8:1923-1928 
Reinaldo Naoto Takahashi, Fabr´ıcio Alano Pamplona, Marcelo Soares Fernandes. (2005) The 
cannabinoid antagonist SR141716A facilitates memory acquisition and consolidation in the 
mouse elevated T-maze. Neurosci. Lett. 380:270-275 
Riedel, W. J., Klaassen, T., Deutz, N. E., van Someren A., van Praag H. M. (1999) Tryptophan 
depletion in normal volunteers produces selective impairment in memory consolidation. 
Psychopharmacology (Berl.) 141: 362-369 
Rubin, E. H., Storandt, M., Miller, J. P., Kinscherf, D. A., Grant, E. A., Morris, J. C., et al. (1998) A 
prospective study of cognitive function and onset of dementia in cognitively healthy elders. Arch. 
Neurol-Chicago 55:395–401 
Stein, L., Belluzzi, J. D., Wise, C. D. (1975) Memory enhancement by central administration of 
norepinephrine. Brain Res. 84:329-335 
Stein, L., Wise, C. D. (1971) Possible etiology of schizophrenia: Progressive damage to the 
noradrenergic reward system by 5-hydroxydopamine. Science 171:1032-1036 
Tierney, M. C., Yao, C., Kiss, A., McDowell, I. (2005) Neuropsychological tests accurately predict 
incident Alzheimer disease after 5 and 10 years. Neurology 64:1853-1859 
Topic, B., Tani, E., Tsiakitzis, K., Kourounakis, P. N., Dere, E., Hasenöhrl, R. U., et al. (2002) 
 27 
Enhanced maze performance and reduced oxidative stress by combined extracts of Zingiber 
officinale and Ginkgo biloba in the aged rat. Neurobiol. Aging 23:135-143 
Trond Myhrer. (2003) Neurotransmitter systems involved in learning and memory in the rat: a 
meta-analysis based on studies of four behavioral tasks. Brain Res. Rev. 41:268-287 
Türkmen, Ş., Löfgren, M., Birzniece, V., Bäckström, T., Johansson, I. M. (2006) Tolerance 
development to Morris water maze test impairments induced by acute alopregnanolone. 
Neuroscience 139: 651-659 
Um, M. Y., Choi, W. H., Aan, J. Y., Kim, S. R., Ha, T. Y. (2006) Protective effect of Polygonum 
multiflorum Thunb on amyloid β-peptide 25-35 induced cognitive deficits in mice. J. 
Ethnopharmacol. 104:144-148 
Uttl, B., Graf, P. (1993) Episodic spatial memory in adulthood. Psychol. Aging 8:257-273 
Wilkniss, S. M., Jones, M. G., Korol, D. L., Manning, C. A. (1997) Age-related differences in an 
ecologically-based study of route learning. Psychol. Aging 12:372-375 
Wilson, C., Nomikos, G. G., Collu, M., Fibiger, H. C. (1995) Dopaminergic correlates of motivated 
behavior: Importance of drive. J. Neurosci. 15 :5169-5178 
Wu, B., Fang, Y. Q. (2004) Material basis and mechanism of action study on Nootropic Acori 
graminei rhizoma. Chinese Archives of Traditional Chinese Medicine 22:1635-1636 
Xu Shu-yun, Bian Ru-lian, Chen Xiu. (2002) Experimental methodology of pharmacology. (third 
version) Beijing: Peoples’ medical publishing house. pp826-828 
Yoshifumi, I., Wing, M. K. (2003) Rhizoma acori graminei and its active principles protect PC-12 






Table 1    Effects of EO on learning performances in aged mice  
Group         N      Dose         Latency           Number of errors 
                         (g/kg.d-1)      (second)            (time/5min) 
Normal          10     vehicle      135.30±21.88        2.10±1.73 
Control          10     vehicle      75.10±20.63△△△          7.70±4.22△△△ 
  Essential oil      10     0.08         112.60±31.52**       3.80±2.35* 
  Essential oil      10     0.04         104.40±28.22*        4.70±2.11* 
  Essential oil      10     0.02         96.60±30.11          6.30±3.65 
   △△△  P < 0.001 compared with normal mice; *P < 0.05, **P < 0.01 compared with control aged 
mice. Data are presented as mean ± SD. 
 
Table 2    Effects of EO on learning performances in aged rats       
Group          N         Dose        Latency          Number of errors 
                          (g/kg.d-1)      (second)          (time/10 times) 
Normal         10        vehicle       13.40±6.02          2.60±2.41 
Control         10        vehicle       40.50±22.09△△       6.50±2.27△△ 
  Essential oil     10         0.08        17.90±9.15**         3.00±2.45**   
  Essential oil     10         0.04        17.60±9.57**         3.00±2.11**    
  Essential oil     10         0.02        21.50±16.29*         5.00±2.00  
   △△  P < 0.01 compared with normal rats; *P < 0.05, **P < 0.01 compared with control aged rats. 
Data are presented as mean ± SD. 
 
Table 3    Effects of EO on dysmnesia mice induced by scopolamine   
Group          N         Dose        Latency          Number of errors 
                          (g/kg.d-1)      (second)           (time/5min) 
Normal         10        vehicle       116.70±59.05       2.20±1.87 
Control         10        vehicle       40.30±27.31△△      6.70±3.59△△ 
  Essential oil     10         0.08        83.00±47.66*        2.60±1.84**   
  Essential oil     10         0.04        88.40±57.30*        2.10±2.51**    
  Essential oil     10         0.02        88.50±48.67*        2.80±1.93** 
   △△  P < 0.01 compared with normal mice; *P < 0.05, **P < 0.01 compared with control mice. 
Data are presented as mean ± SD. 
 
Table 4    Effects of EO on dysmnesia rats induced by sodium nitrite       
Group          N         Dose        Latency          Number of errors 
                          (g/kg.d-1)      (second)          (time/10 times) 
Normal         10        vehicle       16.10±7.81         2.40±2.06 
Control         10        vehicle       35.50±19.72△△      5.20±1.32△△ 
  Essential oil     10         0.08        17.10±10.56*        2.70±1.94**   
  Essential oil     10         0.04        18.70±10.61*        2.90±2.38*    
  Essential oil     10         0.02        19.20±8.15*         3.60±1.26*  
   △△  P < 0.01 compared with normal rats; *P < 0.05, **P < 0.01 compared with control rats. Data 
are presented as mean ± SD. 
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Table 5    Effects of EO on dysmnesia mice induced by ethanol   
Group          N         Dose        Latency          Number of errors 
                          (g/kg.d-1)      (second)           (time/5min) 
Normal         10        vehicle       95.40±35.52        3.70±0.82 
Control         10        vehicle       22.40±10.57△△      7.80±4.10△△ 
  Essential oil     10         0.08        91.40±50.12**       3.60±1.58** 
  Essential oil     10         0.04        88.80±49.58**       3.80±1.62** 
  Essential oil     10         0.02        77.70±45.85*        4.30±2.91* 
   △△  P < 0.01 compared with normal mice; *P < 0.05, **P < 0.01 compared with control mice. 
Data are presented as mean ± SD. 
 
Table 6    Effects of EO on cerebral 5-HT, NE, and DA levels in aged rats 
Group       N       Dose         5-HT            NE                DA 
                      (g/kg.d-1)      (ng/g)           (ng/g)              (ng/g) 
Normal      10      vehicle     552.80±134.31       476.20±73.87      3655.50±1086.66 
Control      10      vehicle     399.50±151.11△     381.70±34.61△△     2430.40±692.58△ 
  Essential oil  10      0.08        658.20±220.43**    441.70±64.79*      4269.90±1586.87** 
  Essential oil  10      0.04        540.30±214.74     569.90±86.47***    3482.80±926.59* 
  Essential oil  10      0.02        425.20±153.98     430.10±43.57*      2817.70±1145.74 
   △ P < 0.05, △△  P < 0.01 compared with normal rats; *P < 0.05, **P < 0.01, ***P < 0.001 
compared with control aged rats. Data are presented as mean ± SD. 
 
Figure 
































△△  P < 0.01 compared with normal rats; *P < 0.05, **P < 0.01 compared with control aged rats. Ten 
animals were used per group. The values represent the mean ± SD. 
 
